Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 11:150:e205.
doi: 10.1017/S095026882200139X.

Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant Campylobacter spp. infections - a scoping review

Affiliations

Characterisation of burden of illness measures associated with human (Fluoro)quinolone-resistant Campylobacter spp. infections - a scoping review

M J Isada et al. Epidemiol Infect. .

Abstract

Campylobacter spp. are one of the most common causes of bacterial gastroenteritis in Canada and worldwide. Fluoroquinolones are often used to treat complicated human campylobacteriosis and strains of Campylobacter spp. resistant to these drugs are emerging along the food chain. A scoping review was conducted to summarise how human (fluoro)quinolone-resistant (FQR; quinolones including fluoroquinolones) Campylobacter spp. infections are characterised in the literature by describing how burden of illness (BOI) associated with FQR is measured and reported, describing the variability in reporting of study characteristics, and providing a narrative review of literature that compare BOI measures of FQR Campylobacter spp. infections to those with susceptible infections. The review identified 26 studies that yielded many case reports, a lack of recent literature and a lack of Canadian data. Studies reported 26 different BOI measures and the most common were hospitalisation, diarrhoea, fever and duration of illness. There were mixed results as BOI measures reported in literature were inconsistently defined and there were limited comparisons between resistant and susceptible infections. This presents a challenge when attempting to assess the magnitude of the BOI due to FQR Campylobacter spp., highlighting the need for more research in this area.

Keywords: Burden of illness; Campylobacter spp.; fluoroquinolone resistance; human infections; scoping review.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Literature search and screening process for a scoping review of BOI measures related to human (fluoro)quinolone-resistant Campylobacter spp. infections (adapted from [26]).
Fig. 2.
Fig. 2.
Years of data collection and publication period for data included in the scoping review of BOI measures related to human (fluoro)quinolone-resistant Campylobacter spp. infections. *Frequency of Data Collection: each year of data during a multi-year collection period is recorded as one value.

References

    1. Thomas MK et al. (2013) Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006. Foodborne Pathogens and Disease 10, 639–648. - PMC - PubMed
    1. World Health Organization (2015) WHO estimates of the global burden of foodborne diseases. Available at https://apps.who.int/iris/bitstream/handle/10665/199350/9789241565165_en... (Accessed 13 December 2021).
    1. Public Health Agency of Canada (2018) Campylobacteriosis (Campylobacter). Available at https://www.canada.ca/en/public-health/services/diseases/campylobacterio... (Accessed 13 December 2021).
    1. Riley A et al. (2015) Antibiotic susceptibility of clinical isolates of Campylobacter jejuni and Campylobacter coli in Ontario, Canada during 2011–2013. Diagnostic Microbiology and Infectious Disease 83, 292–294. - PubMed
    1. Blaser MJ and Engberg J (2008) Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. In Nachamkin I, Szymanski CM and Blaser MJ (eds), Campylobacter, 3rd Edn. Washington: American Society of Microbiology, pp. 99–121.

Publication types

MeSH terms